Role of microRNAs in endothelial inflammation and senescence

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4509-4518

  Qin, Bing ^a   Yang, Huan ^a   Xiao, Bo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelial cells; Inflammation; MicroRNA; Senescence

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; MICRORNA; MICRORNA 10A; MICRORNA 125A 5P; MICRORNA 125B 5P; MICRORNA 126; MICRORNA 155; MICRORNA 17 3P; MICRORNA 17 92; MICRORNA 200C; MICRORNA 217; MICRORNA 221; MICRORNA 222; MICRORNA 31; MICRORNA 34A; MICRORNA 663; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

3' UNTRANSLATED REGION; ALLELE; CELL AGING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL INFLAMMATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; ENDOTHELIUM CELL; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL AGING; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICRORNAS;

EID: 84863093927     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1241-0     Document Type: Review

References (86)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367(9524):1747-1757. doi:10.1016/S0140-6736(06) 68770-9
2. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196(2):193-222. doi:10.1111/j.1748-1716.2009.01964.x
3. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685-1695. doi:10.1056/NEJMra043430
4. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868-874. doi:10.1038/nature01323nature01323
5. Schleser S, Ringseis R, Eder K (2006) Conjugated linoleic acids have no effect on TNF alpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis 186(2):337-344. doi:10.1016/j.atherosclerosis.2005.08.018
6. Chae YJ, Kim CH, Ha TS, Hescheler J, Ahn HY, Sachinidis A (2007) Epigallocatechin-3-O-gallate inhibits the angiotensin IIinduced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol Biochem 20(6):859-866. doi:10.1159/000110446110446
7. Brandes RP, Fleming I, Busse R (2005) Endothelial aging. Cardiovasc Res 66(2):286-294. doi:10.1016/j.cardiores.2004.12.027
8. Minamino T, Komuro I (2007) Vascular cell senescence: contribution to atherosclerosis. Circ Res 100(1):15-26. doi:10.1161/01.RES.0000256837.40544.4a
9. Hayashi T, Yano K, Matsui-Hirai H, Yokoo H, Hattori Y, Iguchi A (2008) Nitric oxide and endothelial cellular senescence. Pharmacol Ther 120(3):333-339. doi:10.1016/j.pharmthera.2008. 09.002
10. Nakajima M, Hashimoto M, Wang F, Yamanaga K, Nakamura N, Uchida T, Yamanouchi K (1997) Aging decreases the production of PGI2 in rat aortic endothelial cells. Exp Gerontol 32(6):685-693
11. Erusalimsky JD, Skene C (2009) Mechanisms of endothelial senescence. Exp Physiol 94(3):299-304. doi:10.1113/expphysiol.2008. 043133
12. Neubert K, Haberland A, Kruse I, Wirth M, Schimke I (1997) The ratio of formation of prostacyclin/thromboxane A2 in HUVEC decreased in each subsequent passage. Prostaglandins 54(1):447-462
13. Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin Sci (Lond) 120(9):357-375. doi:10.1042/CS20100476
14. ZouY,Yoon S, JungKJ, KimCH, Son TG, KimMS, KimYJ, Lee J, YuBP,ChungHY(2006)Upregulation of aortic adhesionmolecules during aging. J Gerontol A Biol Sci Med Sci 61(3):232-244
15. Mariotti M, Castiglioni S, Bernardini D, Maier JA (2006) Interleukin 1 alpha is a marker of endothelial cellular senescent. Immun Ageing 3:4. doi:10.1186/1742-4933-3-4
16. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
17. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9(2):102-114
18. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15(2):272-284. doi:10.1016/j.devcel.2008.07.008
19. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, Kuo CJ (2008) Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135(24):3989-3993. doi:10.1242/dev.029736
20. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN (2008) The endothelialspecific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15(2):261-271. doi:10.1016/j.devcel.2008.07.002
21. Zou J,LiWQ, Li Q, LiXQ, Zhang JT, LiuGQ,Chen J,QiuXX, Tian FJ,Wang ZZ, Zhu N, QinYW, Shen B, Liu TX, Jing Q (2011) Two functional microRNA-126 s repress a novel target gene p21-activated kinase 1 to regulate vascular integrity in zebrafish. Circ Res 108(2):201-209. doi:10.1161/CIRCRESAHA.110. 225045
22. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105(5):1516-1521. doi:10.1073/pnas.0707493105
23. Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ (2010) Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler Thromb Vasc Biol 30(10): 1990-1997. doi:10.1161/ATVBAHA.110.211706
24. Sato Y (2001) Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct 26(1): 19-24
25. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P (2005) Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 115(9): 2508-2516. doi:10.1172/JCI24403
26. Oettgen P (2006) Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 99(11):1159-1166. doi: 10.1161/01.RES.0000251056.85990.db
27. Dejana E, Taddei A, Randi AM (2007) Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 1775(2):298-312. doi:10.1016/j. bbcan.2007.05.003
28. Naito S, Shimizu S, Maeda S, Wang J, Paul R, Fagin JA (1998) Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. Am J Physiol 274(2 Pt 1):C472-C480
29. Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Selzer E, Radda I, Stummvoll GH, Steiner CW, Groger M, Bitzan P, Zenz P, Smolen JS, Steiner G (2001) Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum 44(2):266-274
30. Goetze S, Kintscher U, Kaneshiro K, Meehan WP, Collins A, Fleck E, Hsueh WA, Law RE (2001) TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159(1):93-101
31. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E,Wang S, Olson EN, Schober A,Weber C (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2(100):ra81. doi:10.1126/scisignal.2000610
32. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, WangCW, JeyaseelanK(2009)Expression profile ofMicroRNAs in young stroke patients. PLoS One 4(11):e7689. doi:10.1371/journal.pone.0007689
33. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107(5):677-684. doi:10.1161/CIRCRESAHA.109.215566
34. Granger DN, Vowinkel T, Petnehazy T (2004) Modulation of the inflammatory response in cardiovascular disease. Hypertension 43(5):924-931
35. Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792(6):497-505. doi:10.1016/j.bbadis.2009.02.013
36. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS (2006) MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281(27): 18277-18284. doi:10.1074/jbc.M601496200
37. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, ChotaniM, Feldman DS, Schmittgen TD,EltonTS(2007) The human angiotensin II type 1 receptor ?1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282(33):24262-24269. doi: 0.1074/jbc.M701050200
38. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y (2011) Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. doi:10.1016/j. atherosclerosis.2010.12. 024
39. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33(8):2697-2706. doi:10.1093/nar/gki567
40. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108(9): 3068-3071. doi:10.1182/blood-2006-01-012369
41. Chen Y, Banda M, Speyer CL, Smith JS, Rabson AB, Gorski DH (2010) Regulation of the expression and activity of the antiangiogenic homeobox geneGAX/MEOX2 by ZEB2 andmicroRNA-221. Mol Cell Biol 30(15):3902-3913. doi:10.1128/MCB.01237-09
42. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF (2010) microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30(8):1562-1568. doi:10.1161/ATVBAHA.110.206201
43. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104(4):476-487. doi:10.1161/CIRCRESAHA.108. 185363
44. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100(8):1164-1173. doi:10.1161/01.RES.0000265065.26744.17
45. Suarez Y, Wang C, Manes TD, Pober JS (2010) Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 184(1):21-25. doi:10.4049/jimmunol.0902369
46. Baker RG, Hayden MS, Ghosh S (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metab 13(1):11-22. doi:10.1016/j.cmet.2010.12.008
47. de Winther MP, Kanters E, Kraal G, Hofker MH (2005) Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25(5):904-914. doi:10.1161/01.ATV.0000160340. 72641.87
48. Savoia C, Schiffrin EL (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 112(7):375-384. doi:10.1042/CS20060247
49. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF (2010) MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 107(30):13450-13455. doi:10.1073/pnas.1002120107
50. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412(6844):346-351. doi:10.1038/3508559735085597
51. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW (1999) The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13(3):270-283
52. Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Liu J, Yang Z, Ran Y (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24(1):105-112
53. Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (2010) Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 31(9): 1561-1566. doi:10.1093/carcin/bgq143
54. Ni CW, Qiu H, Jo H (2011) MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol. doi: 10.1152/ajpheart.00829.2010
55. Anggrahini DW, Emoto N, Nakayama K, Widyantoro B, Adiarto S, Iwasa N, Nonaka H, Rikitake Y, Kisanuki YY, Yanagisawa M, Hirata K (2009) Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc Res 82(1):143-151. doi: 10.1093/cvr/cvp026
56. Li D, Yang P, Xiong Q, Song X, Yang X, Liu L, Yuan W, Rui YC (2010) MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens 28(8):1646-1654. doi:10.1097/HJH.0b013e32833a4922
57. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F,Vasa-Nicotera M, Ippoliti A, NovelliG,Melino G, Lauro R, Federici M (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120(15): 1524-1532. doi:10.1161/CIRCULATIONAHA.109. 864629
58. Potente M, Dimmeler S (2008) Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7(14):2117-2122
59. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y (2007) Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 43(5):571-579. doi: 10.1016/j.yjmcc.2007.08.008
60. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. ArchBiochemBiophys 501(1):79-90. doi:10.1016/j.abb.2010. 05.003
61. Ito T, Yagi S, Yamakuchi M (2010) MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 398(4):735-740. doi:10.1016/j.bbrc.2010. 07.012
62. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7):593-600. doi:10.1056/NEJMoa022287348/7/ 593
63. Zhao T, Li J, Chen AF (2010) MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 299(1):E110-E116. doi:10.1152/ajpendo.00192.2010
64. Whaley-Connell A, McCullough PA, Sowers JR (2011) The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 12(1):21-29
65. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, Capogrossi MC (2011) miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. doi:10.1038/cdd.2011.42
66. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 105(37): 14082-14087. doi:10.1073/pnas.0804597105
67. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710-1713. doi: 10.1126/science.1174381
68. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Muck C, Laschober GT, Lepperdinger G, Sampson N, Berger P, Herndler-Brandstetter D, Wieser M, Kuhnel H, Strasser A, Rinnerthaler M, Breitenbach M, Mildner M, Eckhart L, Tschachler E, Trost A, Bauer JW, Papak C, Trajanoski Z, Scheideler M, Grillari-Voglauer R, Grubeck-Loebenstein B, Jansen-Durr P, Grillari J (2010) miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9(2):291-296. doi:10.1111/j.1474-9726.2010.00549.x
69. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax PH, Rabelink TJ, van Zonneveld AJ (2009) Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13(8A):1577-1585. doi:10.1111/j.1582-4934.2008.00613.x
70. Fluiter K, Mook OR, Baas F (2009) The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence. Methods Mol Biol 487:189-203
71. Cook-Mills JM (2006) Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration. Cell Mol Biol (Noisy-le-grand) 52(4):8-16
72. Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C, Gay R, Buckley CD, Tak PP, Gay S, Kyburz D (2011) Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 63(2):373-381. doi:10.1002/art.30115
73. Autiero M, Luttun A, Tjwa M, Carmeliet P (2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1(7):1356-1370
74. Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF (1997) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 14(17):2025-2032. doi:10.1038/sj.onc.1201033
75. Thill M, Berna MJ, Kunst F, Wege H, Strunnikova NV, Gordiyenko N, Grierson R, Richard G, Csaky KG (2011) SU5416 induces premature senescence in endothelial progenitor cells from patients with age-related macular degeneration. Mol Vis 17:85-98
76. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A (2010) miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224(1):242-249. doi:10.1002/jcp.22126
77. Winning S, Splettstoesser F, Fandrey J, Frede S (2010) Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J Immunol 185(3): 1786-1793. doi:10.4049/jimmunol.0903244
78. Michiels C, Arnould T, Remacle J (2000) Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 1497(1):1-10. doi:S0167-4889(00)00041-0
79. Angelo LS, Kurzrock R (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13(10):2825-2830. doi:10.1158/1078-0432.CCR-06-2416
80. Taguchi A, Yanagisawa K, TanakaM, Cao K, Matsuyama Y, Goto H, Takahashi T (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92microRNAcluster.CancerRes 68(14):5540-5545. doi:10.1158/0008-5472.CAN- 07-6460
81. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, Lowenstein CJ (2010) P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107(14):6334-6339. doi:10.1073/pnas. 0911082107
82. Yamakuchi M, Yagi S, Ito T, Lowenstein CJ (2011)MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 6(5):20291. doi:10.1371/journal.pone.0020291PONE-D-11-01497
83. Horwich MD, Zamore PD (2008) Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. Nat Protoc 3(10):1537-1549. doi: 10.1038/nprot.2008.145
84. Mae M, Andaloussi SE, Lehto T, Langel U (2009) Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin Drug Deliv 6(11):1195-1205. doi:10.1517/17425240903213688
85. ZhangG,WangQ,XuR(2010)Therapeutics based onmicroRNA: a new approach for liver cancer. Curr Genomics 11(5):311-325. doi: 10.2174/138920210791616671
86. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, ManoharanM, StoffelM(2005) Silencing ofmicroRNAsin vivo with 'antagomirs'. Nature 438(7068):685-689. doi:10.1038/nature04303